Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder

BACKGROUND: Despite the overall high degree of response to pharmacotherapy, consensus is lacking on how to judge clinical response or define optimal treatment/remission when treating adults with attention-deficit/hyperactivity disorder (ADHD). This study examined clinical response and symptomatic re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Mattingly, Greg W, Weisler, Richard H, Young, Joel, Adeyi, Ben, Dirks, Bryan, Babcock, Thomas, Lasser, Robert, Scheckner, Brian, Goodman, David W
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2013
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3568402/
https://ncbi.nlm.nih.gov/pubmed/23356790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-244X-13-39
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars